【结 构 式】 |
【分子编号】40537 【品名】Tryptamine; 2-(1H-Indol-3-yl)-1-ethanamine; 2-(1H-Indol-3-yl)ethylamine 【CA登记号】61-54-1 |
【 分 子 式 】C10H12N2 【 分 子 量 】160.21876 【元素组成】C 74.97% H 7.55% N 17.48% |
合成路线1
该中间体在本合成路线中的序号:(VIII)Oxidation of 5-hydroxy-5,6,7,8-tetrahydroisoquinoline (I) using CrO3 in pyridine produced the corresponding ketone (II). Subsequent condensation of (II) with methyl cyanoformate (A) in the presence of lithium hexamethyldisilazide gave ketoester (III), which was reduced to hydroxyester (IV) by means of catalytic hydrogenation. Dehydration of (IV) to the unsaturated ester (V) was achieved by treatment with methanesulfonyl chloride and triethylamine, followed by basic elimination with DBU. Saponification of the ester group of (V) produced carboxylic acid (VI). After activation of (VI) as the mixed anhydride (VII) with isopropyl chloroformate (B), coupling with tryptamine (VIII) furnished the title amide, which was finally isolated as the hydrochloride salt.
【1】 May, S.; Chan, L.; Chen, Y.; Jin, H.; Hu, Z.; Bedard, J.; Stefanac, T.; Turcotte, N.; Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors. Bioorg Med Chem Lett 2000, 10, 13, 1477. |
【2】 Bedard, J.; Rando, R.; Falardeau, G.; Lavallee, J.-F. (BioChem Pharma Inc.); Antiviral cpds.. WO 9929318 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 18001 | methyl 2-nitriloacetate; carbonocyanic acid, methyl ester | 17640-15-2 | C3H3NO2 | 详情 | 详情 |
(B) | 26492 | 2-[(chlorocarbonyl)oxy]propane | 108-23-6 | C4H7ClO2 | 详情 | 详情 |
(I) | 40530 | 5,6,7,8-tetrahydro-5-isoquinolinol | C9H11NO | 详情 | 详情 | |
(II) | 40531 | 7,8-dihydro-5(6H)-isoquinolinone | C9H9NO | 详情 | 详情 | |
(III) | 40532 | methyl 5-hydroxy-7,8-dihydro-6-isoquinolinecarboxylate | C11H11NO3 | 详情 | 详情 | |
(IV) | 40533 | methyl 5-hydroxy-5,6,7,8-tetrahydro-6-isoquinolinecarboxylate | C11H13NO3 | 详情 | 详情 | |
(V) | 40534 | methyl 7,8-dihydro-6-isoquinolinecarboxylate | C11H11NO2 | 详情 | 详情 | |
(VI) | 40535 | 7,8-dihydro-6-isoquinolinecarboxylic acid | C10H9NO2 | 详情 | 详情 | |
(VII) | 40536 | C14H15NO4 | 详情 | 详情 | ||
(VIII) | 40537 | Tryptamine; 2-(1H-Indol-3-yl)-1-ethanamine; 2-(1H-Indol-3-yl)ethylamine | 61-54-1 | C10H12N2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)The esterification of 4-formylcinnamic acid (I) with methanol and HCl gives the methyl ester (II), which can be obtained by Heck coupling of 4-bromobenzaldehyde (III) with methyl acrylate (IV). The reductocondensation of (II) with tryptamine (V) by means of NaBH(OAc)3 in dichloroethane yields the secondary amine (VI), which is alkylated with 2-(tert-butyldimethylsilyloxy)ethyl bromide (VII) by means of DIEA in DMSO to afford the tertiary amine (VIII). The reaction of the methyl ester group of (VIII) with KOH and hydroxylamine in methanol provides the silylated hydroxamic acid (IX), which is finally deprotected with TFA in water.
【1】 Perez, L.B.; Remiszewski, S.; Sambucetti, L.; et al.; Discovery and SAR of NVP-LAQ824, a novel histone deacetylase inhibitor with in vitro and in vivo antitumor activity. Proc Am Assoc Cancer Res 2002, 43, Abst 3671. |
【2】 Bair, K.W.; Versace, R.W.; Green, M.A.; Remiszewski, S.W.; Perez, L.B.; Sambucetti, L.; Sharma, S.K. (Novartis AG; Novartis-Erfindungen VmbH); Deacetylase inhibitors. WO 0222577 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 55571 | 4-Formylcinnamic acid | 23359-08-2 | C10H8O3 | 详情 | 详情 |
(II) | 46515 | methyl (E)-3-(4-formylphenyl)-2-propenoate | 7560-50-1 | C11H10O3 | 详情 | 详情 |
(III) | 22231 | 4-Bromobenzaldehyde | 1122-91-4 | C7H5BrO | 详情 | 详情 |
(IV) | 14156 | methyl acrylate | 96-33-3 | C4H6O2 | 详情 | 详情 |
(V) | 40537 | Tryptamine; 2-(1H-Indol-3-yl)-1-ethanamine; 2-(1H-Indol-3-yl)ethylamine | 61-54-1 | C10H12N2 | 详情 | 详情 |
(VI) | 55572 | methyl 3-[4-({[2-(1H-indol-3-yl)ethyl]amino}methyl)phenyl]-2-propenoate | C21H22N2O2 | 详情 | 详情 | |
(VII) | 55573 | 2-Bromoethoxy-t-butyldimethylsilane | 86864-60-0 | C8H19BrOSi | 详情 | 详情 |
(VIII) | 55574 | C29H40N2O3Si | 详情 | 详情 | ||
(IX) | 55575 | 3-[4-({(2-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}ethyl)[2-(1H-indol-3-yl)ethyl]amino}methyl)phenyl]-N-hydroxy-2-propenamide | C28H39N3O3Si | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(IV)2-Aminothiazole (I) is coupled to 3-fluorosulfonylphenyl isocyanate (II) producing the diaryl urea (III). Subsequent reaction of sulfonyl fluoride (III) with tryptamine (IV) in hot acetonitrile furnishes the target sulfonamide.
【1】 Beyer, D.; Kroll, H.; Bauser, M.; Siegel, S.; Brotz, H.; Endermann, R.; Schiffer, G.; Ziegelbauer, K.; Habich, D.; Pohlmann, J.; Phenyl-thiazolylurea-sulfonamides as novel inhibitors of phenylalanine-tRNA synthetase. 42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002, San Diego) 2002, Abst F-756. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 19795 | 2-Thiazolamine; 1,3-thiazol-2-amine; 1,3-thiazol-2-ylamine | 96-50-4 | C3H4N2S | 详情 | 详情 |
(II) | 64472 | 3-isocyanatobenzenesulfonyl fluoride | C7H4FNO3S | 详情 | 详情 | |
(III) | 64473 | 3-{[(1,3-thiazol-2-ylamino)carbonyl]amino}benzenesulfonyl fluoride | C10H8FN3O3S2 | 详情 | 详情 | |
(IV) | 40537 | Tryptamine; 2-(1H-Indol-3-yl)-1-ethanamine; 2-(1H-Indol-3-yl)ethylamine | 61-54-1 | C10H12N2 | 详情 | 详情 |